Related references
Note: Only part of the references are listed.Small but tenacious: South Africa's health biotech sector
Sara Al-Bader et al.
NATURE BIOTECHNOLOGY (2009)
The Indian and Chinese health biotechnology industries: Potential champions of global health?
Sarah E. Frew et al.
HEALTH AFFAIRS (2008)
Brazilian health biotech - fostering crosstalk between public and private sectors
Rahim Rezaie et al.
NATURE BIOTECHNOLOGY (2008)
Chinese health biotech and the billion-patient market
Sarah E. Frew et al.
NATURE BIOTECHNOLOGY (2008)
Current concepts - Control of neglected tropical diseases
Peter J. Hotez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
India's health biotech sector at a crossroads
Sarah E. Frew et al.
NATURE BIOTECHNOLOGY (2007)
Towards the elimination of onchocerciasis
B. Thylefors et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2006)
A breakthrough in R & D for neglected diseases: New ways to get the drugs we need
M Moran
PLOS MEDICINE (2005)
Drug development for neglected diseases: a deficient market and a public-health policy failure
P Trouiller et al.
LANCET (2002)
Drugs for neglected diseases:: a failure of the market and a public health failure?
P Trouiller et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Share Paper
